This compound is primarily used in the synthesis of pharmaceuticals, particularly in the development of chiral molecules. Its structure, featuring a Boc-protected amino group and a methoxyphenyl moiety, makes it a valuable intermediate in the production of active pharmaceutical ingredients (APIs). It is often employed in peptide synthesis and the creation of complex organic molecules, where its chiral center ensures the desired stereochemistry in the final product. Additionally, it serves as a building block in the preparation of compounds targeting neurological and psychiatric disorders, leveraging its methoxyphenyl group for specific receptor interactions. Its application extends to research and development in medicinal chemistry, where it aids in the exploration of new drug candidates with improved efficacy and selectivity.